Vaxxinity Inc. (VAXX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Vaxxinity Inc. (VAXX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.00

-0.00 (-100.00%)

At close: Jan 15, 2025, 9:30 AM

0.10

19780.00%

Pre-market Jun 20, 2024, 09:30 AM EDT

undefined% (undefined)

Bid	n/a
Market Cap	63.39K
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.45
PE Ratio (ttm)	0
Forward PE	n/a
Analyst	Buy

Ask	n/a
Volume	100
Avg. Volume (20D)	29,414
Open	0.00
Previous Close	0.00
Day's Range	0.00 - 0.00
52-Week Range	0.00 - 1.05
Beta	undefined

About VAXX

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synu...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Nov 11, 2021

Employees 57

Stock Exchange NASDAQ

Ticker Symbol VAXX

Website https://www.vaxxinity.com

Analyst Forecast

According to 1 analyst ratings, the average rating for VAXX stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

8 months ago · Source

-43.37%

Vaxxinity shares are trading lower after the compa... Unlock content with Pro Subscription

News

6 months ago · finbold.com

Congress makes $4.5 trading stocks in a day; Here's the biggest winners

Though it isn't unheard of for a member of Congress to have not traded any stocks after getting elected while supporting tighter regulations for politicians' equities market activity, the House and th...

8 months ago · investorplace.com

Why Is Vaxxinity (VAXX) Stock Up 39% Today?

Vaxxinity (NASDAQ: VAXX ) stock is up on Friday with heavy pre-market trading of the biotechnology company's shares. That has more than 21 million shares of VAXX stock changing hands as of this writin...

8 months ago · investorplace.com

Why Is Vaxxinity (VAXX) Stock Down 58% Today?

Vaxxinity (NASDAQ: VAXX ) stock is falling hard on Monday after the biotechnology company announced plans to voluntarily delist its shares from the Nasdaq Exchange. Vaxxinity will file to delist its s...

1 year ago · zacks.com

Alzheimer's Disease Space Evolves in 2023: Stocks in Focus

The approval of the breakthrough treatment Leqembi for Alzheimer's Disease has put this space in the spotlight. Companies like ACIU, VAXX and PRTA are in focus, given their experimental vaccines.

1 year ago · zacks.com

Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)

The heavy selling pressure might have exhausted for Vaxxinity, Inc. (VAXX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana...

1 year ago · 247wallst.com

The 5 Best and Worst Performing Small-Cap Stocks in January 2023

Small-cap stocks are expected to perform well this year. The Bank of America Securities, in fact, is asking investors to consider small caps this year to hedge against a declining market.

1 year ago · fool.com

Why Shares of Vaxxinity Jumped This Week

Investors are hoping the company's COVID-19 vaccine will turn the company from a clinical-stage biotech to a commercial one.

2 years ago · seekingalpha.com

Vaxxinity: Potential Strong Upsides Ahead

We may not be at the end credits for COVID-19 virus. Shares of Vaxxinity, Inc., like most biotechs, have plummeted over the past year due to unprecedented market headwinds, both macroeconomic and geop...

2 years ago · fool.com

Why Shares of Vaxxinity Soared This Week

Positive news regarding a different company's Alzheimer's treatment may have helped Vaxxinity.

2 years ago · investorplace.com

Why Did Vaxxinity (VAXX) Stock Gain 80% Today?

VAXX stock gained more than 80% on Friday after Vaxxinity announced it has enrolled patients for the next part of its trials. The post Why Did Vaxxinity (VAXX) Stock Gain 80% Today?

3 years ago · zacks.com

Vaxxinity (VAXX) Starts Dosing in Parkinson's Disease Study

Vaxxinity (VAXX) starts dosing patients in part B of a phase I study on its investigational Parkinson's disease vaccine candidate.

3 years ago · pulse2.com

Vaxxinity Stock (VAXX): Why The Price Went Up Today

The stock price of Vaxxinity Inc (NASDAQ: VAXX) increased by 29.67% today. This is why it happened.